Yahoo
KOSDAQ - Delayed Quote KRW

TELCON RF PHARMACEUTICAL. Inc. (200230.KQ)

1,884.00 -19.00 (-1.00%)
At close: 3:30:30 PM GMT+9
Chart Range Bar
Loading chart for 200230.KQ
  • Previous Close 1,903.00
  • Open 1,903.00
  • Bid 1,884.00 x --
  • Ask 1,886.00 x --
  • Day's Range 1,884.00 - 1,956.00
  • 52 Week Range 1,700.00 - 11,950.00
  • Volume 7,869
  • Avg. Volume 30,966
  • Market Cap (intraday) 13.451B
  • Beta (5Y Monthly) 0.38
  • PE Ratio (TTM) --
  • EPS (TTM) --
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • 1y Target Est --
  • Moby Rating Neutral

TELCON RF PHARMACEUTICAL. Inc. primarily engages in the development, production, and sale of RF coaxial connectors worldwide. It also provides coaxial couplers, distributors, and arresters, as well as cable assemblies; and pharmaceuticals. The company was formerly known as Telcon Co., Ltd. TELCON RF PHARMACEUTICAL. Inc. was founded in 1999 and is headquartered in Yongin-si, South Korea.

www.telcon.co.kr

--

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/9/2026, which may include dividends or other distributions. Benchmark is KOSPI Composite Index (^KS11) .

YTD Return

200230.KQ
79.45%
KOSPI Composite Index (^KS11)
19.09%

1-Year Return

200230.KQ
81.38%
KOSPI Composite Index (^KS11)
26.94%

3-Year Return

200230.KQ
92.36%
KOSPI Composite Index (^KS11)
106.79%

5-Year Return

200230.KQ
97.72%
KOSPI Composite Index (^KS11)
69.41%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -28.29%

  • Return on Assets (ttm)

    0.15%

  • Return on Equity (ttm)

    -32.70%

  • Revenue (ttm)

    61.78B

  • Net Income Avi to Common (ttm)

    -15.75B

  • Diluted EPS (ttm)

    --

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    36.58B

  • Total Debt/Equity (mrq)

    63.47%

  • Levered Free Cash Flow (ttm)

    -17.55B

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: